HUXLEY PHARMACEUTICALS
Huxley Pharmaceuticals is private life sciences company founded and managed by Aceras BioMedical, LLC. Aceras is dedicated to funding and developing novel innovations that address unmet medical needs.
HUXLEY PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2008-01-01
Status:
Active
Similar Organizations
Neuropn Therapeutics
Neuropn Therapeutics is a biopharmaceutical company located in Peachtree Parkway.
More informations about "Huxley Pharmaceuticals"
HOME | Huxley Health Inc.
Huxley is a team of biotech experts, entrepreneurs, and partners from world-leading institutions, coming together to create a unique and groundbreaking approach to drug development.See details»
Huxley Pharmaceuticals - Crunchbase Company Profile & Funding
Huxley Pharmaceuticals is private life sciences company founded and managed by Aceras BioMedical, LLC. Aceras is dedicated to funding and developing novel innovations that …See details»
HUXEY TEAM | Huxley Health Inc.
With over 30 years of pharmaceutical experience and has held leadership positions in the industry with a focus on international drug development and commercialization. He has proven success …See details»
Huxley Health Inc. Provides Corporate Update
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant ...See details»
Huxley Health Inc. provides corporate update, appoints Bruce …
Jan 30, 2024 BOARD OF DIRECTOR CHANGES On November 15, 2023, Huxley welcomed a new board of directors, and formalized the resignation of Michael Marchese, who has served …See details»
Huxley Health Inc. Provides Corporate Update
Jan 31, 2024 Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant milestones and developments that have shaped Huxley over the past year.See details»
Huxley Health, Inc. (Canada) - Drug pipelines, Patents ... - Patsnap
For full team BIOs please visit: HUXLEY TEAM | Huxley Health Inc. (the-huxley-group.com) NEW MANAGEMENT ADDITIONS Jared Rhines, MBA (Chief Executive Officer): With over 30 years …See details»
Huxley Pharmaceuticals 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for Huxley Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Huxley Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Huxley Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
BioMarin Acquires Huxley Pharmaceuticals, Inc. - Fierce Biotech
Oct 27, 2009 Huxley Pharmaceuticals, Inc. is private life sciences company founded and managed by Aceras BioMedical, LLC. Aceras is dedicated to funding and developing novel …See details»
Huxley Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Huxley Pharmaceuticals is private life sciences company founded and managed by Aceras BioMedical, LLC.See details»
Huxley Pharmaceuticals Inc - Company Profile and News
Company profile page for Huxley Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Huxley Health Inc. Provides Corporate Update - Financial Post
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Huxley Health Inc. (“ Huxley ” or the “ Company ”) is pleased to provide you with a comprehensive corporate update, highlighting …See details»
Huxley Pharmaceuticals acquired by BioMarin Pharmaceutical
Huxley Pharmaceuticals Huxley Pharmaceuticals is private life sciences company founded and managed by Aceras BioMedical, LLC.See details»
Huxley Pharmaceuticals, Inc. · 1251 Ave of The Americas 20
HUXLEY PHARMACEUTICALS, INC. (DOS #3770089) is a Foreign Business Corporation in New York registered with the New York State Department of State (NYSDOS). The business entity …See details»
$15M: BioMarin Buys Huxley, Picks Up Rare Disease Drug
Oct 28, 2009 Staff Writer BioMarin Pharmaceutical Inc. has acquired Aceras BioMedical LLC's portfolio company, Huxley Pharmaceuticals Inc., for $15 million. Huxley shareholders could …See details»
BioMarin buys Huxley Pharma for $15 million plus up to …
Oct 27, 2009 BioMarin Pharmaceutical says that it has acquired fellow USA-based Huxley Pharmaceuticals, which has rights to a proprietary form of 3,4-diaminopyridine (3,4-DAP), …See details»
Huxley Pharmaceuticals Inc in New York City, NY 10020 Directions ...
This organization is involved in Local Business as well as other possible related aspects and functions of Local Business. In New York New York Huxley Pharmaceuticals Inc maintains its …See details»
The Huxley Group - PitchBook
Dec 22, 2022 General Information Description Developer of psychedelic-inspired therapeutics and technologies intended to provide cures for patients with neuropsychiatric conditions. The …See details»
Huxley Health Inc. Provides Corporate Update - PharmiWeb.com
Jan 30, 2024 Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Huxley Health Inc. (“ Huxley ” …See details»